Caseflicks

Supreme Court of the United States • 1992

Indopco, Inc. v. Commissioner

503 U.S. 79 | 112 S. Ct. 1039 | 117 L. Ed. 2d 226 | 1992 U.S. LEXIS 1374 | 6 Fla. L. Weekly Fed. S 31 | 60 U.S.L.W. 4173 | 92 Cal. Daily Op. Serv. 1598 | 92 Daily Journal DAR 2556

Full access

Unlock the video and quiz

The written brief is free to read below. Subscribe to watch the video explainer and take the quiz.

Create an account Log in

Takeaway

In short, this case establishes that a cost may have to be capitalized when it produces significant long-term business benefits, even if it creates no separate and distinct asset.

Background

National Starch and Chemical Corporation, later renamed INDOPCO, was a publicly traded chemical-products company. In 1977, Unilever expressed interest in acquiring it through a friendly transaction. Because National Starch’s largest shareholders, Frank and Anna Greenwall, wanted a tax-free exchange for their shares, the parties structured the deal as a reverse-subsidiary cash merger. Some shareholders exchanged National Starch shares for preferred stock in a Unilever subsidiary, while the remaining shares were converted to cash.

National Starch’s directors were advised that Delaware law required them to ensure the transaction was fair to shareholders. The company retained Morgan Stanley to evaluate the offer, provide a fairness opinion, and assist if a hostile bid emerged. It also used its regular law firm and incurred accounting, printing, proxy-solicitation, and SEC-related costs. The transaction closed in August 1978, making National Starch a wholly owned Unilever subsidiary.

National Starch deducted its Morgan Stanley fees on its 1978 return and later sought to deduct its legal and miscellaneous transaction costs as well. The Commissioner disallowed the deduction. The Tax Court held that all of the expenditures were capital expenses because the acquisition conferred long-term benefits on National Starch. The Third Circuit affirmed. The Supreme Court granted certiorari to resolve disagreement among the circuits about whether an expenditure must create or enhance a separate and distinct asset before it may be capitalized.

Issues

Issue #1

Whether an expenditure must create or enhance a separate and distinct asset before it can be treated as a nondeductible capital expenditure under Internal Revenue Code § 263.

Holding

No. Creating or enhancing a separate and distinct asset is sufficient to require capitalization, but it is not a necessary condition for capitalization.

Reasoning

Section 162(a) permits current deductions for ordinary and necessary expenses incurred in carrying on a trade or business, while § 263 disallows deductions for capital expenditures. The classification matters because ordinary expenses are deducted immediately, whereas capital costs generally are recovered over time or when the enterprise ends. The Code's matching principle therefore requires distinguishing costs tied to the current year from costs that benefit future periods.

The Court rejected National Starch's reading of Commissioner v. Lincoln Savings & Loan Assn. Lincoln Savings held that an expenditure creating or enhancing a separate and distinct asset is capital in nature. But that case did not decide, and therefore did not foreclose, capitalization of expenditures that produce no separately identifiable asset.

A future benefit alone may not always compel capitalization, particularly when it is merely incidental. But the duration and extent of benefits beyond the taxable year remain important indicators of a capital expenditure. Section 263's reference to permanent improvements and betterments itself calls for attention to whether a payment produces enduring advantages.

Issue #2

Whether National Starch could currently deduct its investment-banking, legal, and related professional costs incurred in Unilever's friendly acquisition of the company.

Holding

No. The acquisition-related costs were capital expenditures, not currently deductible ordinary and necessary business expenses under § 162(a).

Reasoning

National Starch did not show that the costs were ordinary business expenses rather than expenditures producing substantial long-term benefits. The record supported the lower courts' finding that Unilever's resources, including its technological capacity and related business operations, offered National Starch enduring opportunities and possible operating synergies.

The transaction also fundamentally changed National Starch's corporate position. It ceased to be an independent public company with thousands of shareholders and became a wholly owned Unilever subsidiary. That change reduced continuing shareholder-relations burdens, including public reporting and disclosure obligations, proxy contests, and derivative litigation risks.

The acquisition enabled further structural simplification, including elimination of previously authorized but unissued preferred shares and a sharp reduction in authorized common shares. Expenses incurred to change a corporation's structure for the benefit of future operations have traditionally been treated as capital costs. The professional fees here had those same capital characteristics even though they did not create a separate and distinct asset.